跳至主要内容
临床试验/EUCTR2016-001126-33-GB
EUCTR2016-001126-33-GB进行中(未招募)1 期

A placebo-controlled double blind, randomised feasibility trial of Desmopressin (DDAVP) in critical illness prior to procedures. - DRIVE - Desmopressin for procedures or Radiological InterVEntions

HS Blood and Transplant0 个研究点目标入组 40 人开始时间: 2016年9月19日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Adult patients (age 18 years or above)
  • Platelet count =100 x 109/L
  • Inpatient on a critical care ward
  • Due to undergo an interventional procedure
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Active bleeding
  • History of ischaemic heart disease (myocardial infarction or angina), stroke or transient ichaemic attack (TIA)
  • Admission to ICU with traumatic brain injury or seizures
  • Congenital bleeding disorder
  • Pregnant or breastfeeding
  • History of anaphylaxis to desmopressin

研究者

发起方
HS Blood and Transplant

相似试验

A randomised controlled trial to evaluate the... | 临床试验